These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8979247)

  • 1. Small molecule ligands for oxytocin and vasopressin receptors.
    Freidinger RM; Pettibone DJ
    Med Res Rev; 1997 Jan; 17(1):1-16. PubMed ID: 8979247
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular recognition of peptide and non-peptide ligands by the extracellular domains of neurohypophysial hormone receptors.
    Howl J; Wheatley M
    Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):577-82. PubMed ID: 8713088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the non-peptide inhibitor OPC-21268 on oxytocin and vasopressin stimulation of rat and human myometrium.
    Atke A; Vilhardt H; Hauzerova L; Barth T; Andersen LF
    Eur J Pharmacol; 1995 Jul; 281(1):63-8. PubMed ID: 8566118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin and oxytocin in normal reproduction and in the pathophysiology of preterm labour and primary dysmenorrhoea. Development of receptor antagonists for therapeutic use in these conditions.
    Akerlund M
    Rocz Akad Med Bialymst; 2004; 49():18-21. PubMed ID: 15631309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nonpeptide oxytocin receptor antagonist radioligand highly selective for human receptors.
    Lemaire W; O'Brien JA; Burno M; Chaudhary AG; Dean DC; Williams PD; Freidinger RM; Pettibone DJ; Williams DL
    Eur J Pharmacol; 2002 Aug; 450(1):19-28. PubMed ID: 12176104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of YM218, a nonpeptide vasopressin V1A receptor-selective antagonist, on human vasopressin and oxytocin receptors.
    Tahara A; Tsukada J; Tomura Y; Kusayama T; Wada K; Ishii N; Taniguchi N; Suzuki T; Yatsu T; Uchida W; Shibasaki M
    Pharmacol Res; 2005 Mar; 51(3):275-81. PubMed ID: 15661579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxytocin and vasopressin in the medial amygdala differentially modulate approach and avoidance behavior toward illness-related social odor.
    Arakawa H; Arakawa K; Deak T
    Neuroscience; 2010 Dec; 171(4):1141-51. PubMed ID: 20933576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docking ligands to vasopressin and oxytocin receptors via genetic algorithm.
    Politowska E; Drabik P; Kazmierkiewicz R; Ciarkowsk J
    J Recept Signal Transduct Res; 2002; 22(1-4):393-409. PubMed ID: 12503629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-peptide oxytocin agonists.
    Pitt GR; Batt AR; Haigh RM; Penson AM; Robson PA; Rooker DP; Tartar AL; Trim JE; Yea CM; Roe MB
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4585-9. PubMed ID: 15357997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenesis and the study of expression, cellular targeting and function of oxytocin, vasopressin and their receptors.
    Young WS; Gainer H
    Neuroendocrinology; 2003 Oct; 78(4):185-203. PubMed ID: 14583651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxytocin and vasopressin V(1A) receptors as new therapeutic targets in assisted reproduction.
    Pierzynski P
    Reprod Biomed Online; 2011 Jan; 22(1):9-16. PubMed ID: 21130036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxytocin and vasopressin enhance synaptic transmission in the hypoglossal motor nucleus of young rats by acting on distinct receptor types.
    Wrobel LJ; Reymond-Marron I; Dupré A; Raggenbass M
    Neuroscience; 2010 Feb; 165(3):723-35. PubMed ID: 19896520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent agonists and antagonists for vasopressin/oxytocin G protein-coupled receptors: usefulness in ligand screening assays and receptor studies.
    Mouillac B; Manning M; Durroux T
    Mini Rev Med Chem; 2008 Sep; 8(10):996-1005. PubMed ID: 18782052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial expression of vasopressin, oxytocin and their receptors in patients with primary dysmenorrhoea and healthy volunteers at ovulation.
    Liedman R; Hansson SR; Howe D; Igidbashian S; Russell RJ; Akerlund M
    Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):189-92. PubMed ID: 18082926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-(1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4- yl)-4H-3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist.
    Williams PD; Clineschmidt BV; Erb JM; Freidinger RM; Guidotti MT; Lis EV; Pawluczyk JM; Pettibone DJ; Reiss DR; Veber DF
    J Med Chem; 1995 Nov; 38(23):4634-6. PubMed ID: 7473590
    [No Abstract]   [Full Text] [Related]  

  • 16. Discovery and development of non-peptide antagonists of peptide hormone receptors.
    Pettibone DJ; Freidinger RM
    Biochem Soc Trans; 1997 Aug; 25(3):1051-7. PubMed ID: 9388600
    [No Abstract]   [Full Text] [Related]  

  • 17. Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women.
    Akerlund M; Bossmar T; Brouard R; Kostrzewska A; Laudanski T; Lemancewicz A; Serradeil-Le Gal C; Steinwall M
    Br J Obstet Gynaecol; 1999 Oct; 106(10):1047-53. PubMed ID: 10519430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for the activation and ligand recognition of the human oxytocin receptor.
    Waltenspühl Y; Ehrenmann J; Vacca S; Thom C; Medalia O; Plückthun A
    Nat Commun; 2022 Jul; 13(1):4153. PubMed ID: 35851571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New opportunities in vasopressin and oxytocin research: a perspective from the amygdala.
    Stoop R; Hegoburu C; van den Burg E
    Annu Rev Neurosci; 2015 Jul; 38():369-88. PubMed ID: 26154981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin stimulates ventromedial hypothalamic neurons via oxytocin receptors in oxytocin gene knockout male and female mice.
    Ragnauth AK; Goodwillie A; Brewer C; Muglia LJ; Pfaff DW; Kow LM
    Neuroendocrinology; 2004; 80(2):92-9. PubMed ID: 15528951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.